<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01958138</url>
  </required_header>
  <id_info>
    <org_study_id>1995-Ane-ERC-11</org_study_id>
    <nct_id>NCT01958138</nct_id>
  </id_info>
  <brief_title>Isoflurane Versus Propofol for Removal of LMA in Children</brief_title>
  <official_title>Isoflurane Versus Combination Of Propofol With Isoflurane For Removal Of Laryngeal Mask Airway In Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will be done in paediatric patients by comparing two different techniques of&#xD;
      Laryngeal Mask Airway (LMA) removal under deep anesthetic plane.&#xD;
&#xD;
      The both study techniques will be compared for safe LMA removal on the basis of adverse&#xD;
      airway events and emergence time duration and recovery room stay timing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Study will be start after confirming the approval of institutional ethical review&#xD;
           committee and after fulfilling the study inclusion criteria. The detailed study protocol&#xD;
           will be explain to the parent/guardian and written &amp; informed consent will be taking on&#xD;
           his/her will.&#xD;
&#xD;
        -  Inclusion Criteria&#xD;
&#xD;
             -  Age between 2 to 10 years,&#xD;
&#xD;
             -  American Society of Anaesthesiologists (ASA) physical status I &amp; II,&#xD;
&#xD;
             -  Patient is not contraindicated to Laryngeal Mask Airway insertion,&#xD;
&#xD;
             -  Elective below umbilical general surgical procedures&#xD;
&#xD;
             -  patient is planned for general anesthesia with spontaneous breathing.&#xD;
&#xD;
        -  Fifty patients will participate in both study groups.&#xD;
&#xD;
        -  All patients will be premedicated with oral midazolam 0.3mg/kg, 45 to 60 minutes prior&#xD;
           to induction.&#xD;
&#xD;
        -  After arrival of patients in operating room, routine anesthesia monitoring will be&#xD;
           applied and baseline blood pressure, heart rate, respiratory rate and oxygen saturation&#xD;
           will be recorded.&#xD;
&#xD;
        -  Patient will be induced with anesthetic induction inhalational agent (sleeping drug)&#xD;
           sevoflurane 8% with oxygen by pediatric anesthesia circle system. The sevoflurane&#xD;
           concentration will be adjusted to 3% to 4% once the adequate depth of anesthesia&#xD;
           achieved, as evident by jaw relaxation and tolerance of an oral airway.&#xD;
&#xD;
        -  The LMA will be placed after the insertion of intravenous line.&#xD;
&#xD;
        -  The LMA size will be determined as per manufacturer's recommendation; which suggest 1.5&#xD;
           LMA size for 5-10 kg, size 2 for 10-20 kg and size 2.5 for 20-30 kg.&#xD;
&#xD;
        -  The anesthesia will be maintained with isoflurane in 60% nitrous oxide and 40% oxygen.&#xD;
           Patients will be ventilated by spontaneous mode by 'Mapleson F anesthesia circuit' and&#xD;
           for above 25 Kg patient, the circle system will be used.&#xD;
&#xD;
        -  Caudal analgesia was standardised in both study groups.&#xD;
&#xD;
        -  Prior to LMA removal in group-I, isoflurane MAC awake (MAC less than 0.5) will be&#xD;
           achieved in expiratory gases with 60% nitrous oxide and 40% oxygen. Propofol 1 mg/Kg&#xD;
           will be combined with Isoflurane MAC awake and LMA will be removed after 20 seconds of&#xD;
           propofol administration in group-I.&#xD;
&#xD;
      The group-II LMA will removed at end expiratory isoflurane MAC of 1.2% with 60% nitrous oxide&#xD;
      and 40% oxygen. In both groups; LMA will be removed with inflated cuff, throat was suctioned&#xD;
      and patients were turned into lateral recovery position.&#xD;
&#xD;
      Isoflurane and nitrous oxide were turned off and 100% oxygen supplemented till the patient&#xD;
      had regained consciousness. All participants were transported to Post Anesthesia Care Unit&#xD;
      (PACU) once ensured airway patency and peripheral oxygen saturation (Sp02) greater than 93%&#xD;
      on room air. Children were allowed to wake up effortlessly in PACU at oxygen 5&#xD;
      litters/minutes via Hudson mask.&#xD;
&#xD;
      - The following study variables will be recorded;&#xD;
&#xD;
        1. Emergence time ( patient awakening time),&#xD;
&#xD;
        2. Duration of recovery room stay (Post anesthesia care unit),&#xD;
&#xD;
        3. Smooth Laryngeal Mask Airway removal will be assessed by&#xD;
&#xD;
             -  Cough,&#xD;
&#xD;
             -  Hypersalivation,&#xD;
&#xD;
             -  02 desaturation &lt; 90%,&#xD;
&#xD;
             -  Teeth clenching,&#xD;
&#xD;
             -  Airway obstruction requiring jaw support,&#xD;
&#xD;
             -  Laryngospasm,&#xD;
&#xD;
             -  Bronchospasm,&#xD;
&#xD;
             -  Retching,&#xD;
&#xD;
             -  Vomiting,&#xD;
&#xD;
        4. Confounding variables will be assessed like;&#xD;
&#xD;
             -  Patients demographics,&#xD;
&#xD;
             -  Duration of surgery,&#xD;
&#xD;
             -  Duration of anesthesia,&#xD;
&#xD;
             -  Type of surgery,&#xD;
&#xD;
             -  Mode of analgesia&#xD;
&#xD;
             -  Number of Laryngeal Mask Airway insertion attempts:&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emergence airway complications</measure>
    <time_frame>15 minutes of continuous monitoring and time frame was started from the LMA removal</time_frame>
    <description>Smooth LMA removal will be assessed by adverse airway events like; coughing, bucking, hypersalivation, O2 desaturation (Sp02&lt;90%), airway obstruction (noisy or stridor breathing) requiring jaw support, laryngospasm, bronchospasm, retching and vomiting, time duration from LMA removal up to 15 minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Emergence time duration</measure>
    <time_frame>15 minutes of continuous monitoring and time frame was started from the LMA removal</time_frame>
    <description>Impact on emergence time duration because of intervention such as delayed awakening or responding</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post anaesthesia care unit stay time duration</measure>
    <time_frame>0-45 minutes of continuous monitoring and time frame was started from the PACU admission to discharge</time_frame>
    <description>Impact of intervention on post anaesthesia care unit admission to discharge time duration</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Complication of Anesthesia</condition>
  <arm_group>
    <arm_group_label>propofol with Isoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol with Isoflurane, Group-I is the intervention arm with combination of two drugs such as low dose propofol and Isoflurane MAC awake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alone isoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group-II is the control arm of study by using the only Isoflurane 1.2 MAC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of group-I (low dose propofol with isoflurane)</intervention_name>
    <description>Prior to LMA removal in group-I, isoflurane MAC awake (MAC less than 0.5) will be achieved in expiratory gases with 60% nitrous oxide and 40% oxygen. Propofol 1 mg/Kg will be combined with Isoflurane MAC awake and LMA will be removed after 20 seconds of propofol administration in group-I. The group-II LMA will be removed at end expiratory isoflurane MAC of 1.2% with 60% nitrous oxide and 40% oxygen</description>
    <arm_group_label>alone isoflurane</arm_group_label>
    <arm_group_label>propofol with Isoflurane</arm_group_label>
    <other_name>group-II (alone isoflurane MAC 1.2%)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologist class-I &amp; II patients.&#xD;
&#xD;
          -  mallampatis class I &amp; II.&#xD;
&#xD;
          -  Age from 2 years to 10 years.&#xD;
&#xD;
          -  Elective surgical patients for below umbilical general surgical procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital disorders&#xD;
&#xD;
          -  Airway or facial abnormalities&#xD;
&#xD;
          -  Reactive airway disease/asthma&#xD;
&#xD;
          -  Anticipated difficult airway&#xD;
&#xD;
          -  History of Upper respiratory tract infection in last 3 weeks&#xD;
&#xD;
          -  History of gastroesophageal reflux disorders&#xD;
&#xD;
          -  Known allergic to isoflurane and propofol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>dileep kumar, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University Hospital Karachi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Operating room at Aga Khan University Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>3500</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Frediani M, Blanchini G, Capanna M, Casini L, Costa M, Uggeri S, Meini M, Pacini P. [The laryngeal mask in pediatric anesthesia]. Minerva Anestesiol. 1996 Mar;62(3):65-71. Italian.</citation>
    <PMID>8767151</PMID>
  </reference>
  <reference>
    <citation>Brain AI. The laryngeal mask--a new concept in airway management. Br J Anaesth. 1983 Aug;55(8):801-5.</citation>
    <PMID>6349667</PMID>
  </reference>
  <reference>
    <citation>Samarkandi AH. Awake removal of the laryngeal mask airway is safe in paediatric patients. Can J Anaesth. 1998 Feb;45(2):150-2.</citation>
    <PMID>9512850</PMID>
  </reference>
  <reference>
    <citation>Splinter WM, Reid CW. Removal of the laryngeal mask airway in children: deep anesthesia versus awake. J Clin Anesth. 1997 Feb;9(1):4-7.</citation>
    <PMID>9051538</PMID>
  </reference>
  <reference>
    <citation>Nunez J, Hughes J, Wareham K, Asai T. Timing of removal of the laryngeal mask airway. Anaesthesia. 1998 Feb;53(2):126-30.</citation>
    <PMID>9534633</PMID>
  </reference>
  <reference>
    <citation>Pappas AL, Sukhani R, Lurie J, Pawlowski J, Sawicki K, Corsino A. Severity of airway hyperreactivity associated with laryngeal mask airway removal: correlation with volatile anesthetic choice and depth of anesthesia. J Clin Anesth. 2001 Nov;13(7):498-503.</citation>
    <PMID>11704447</PMID>
  </reference>
  <reference>
    <citation>Baird MB, Mayor AH, Goodwin AP. Removal of the laryngeal mask airway: factors affecting the incidence of post-operative adverse respiratory events in 300 patients. Eur J Anaesthesiol. 1999 Apr;16(4):251-6.</citation>
    <PMID>10234495</PMID>
  </reference>
  <reference>
    <citation>Kitching AJ, Walpole AR, Blogg CE. Removal of the laryngeal mask airway in children: anaesthetized compared with awake. Br J Anaesth. 1996 Jun;76(6):874-6.</citation>
    <PMID>8679367</PMID>
  </reference>
  <reference>
    <citation>Afshan G, Chohan U, Qamar-Ul-Hoda M, Kamal RS. Is there a role of a small dose of propofol in the treatment of laryngeal spasm? Paediatr Anaesth. 2002 Sep;12(7):625-8.</citation>
    <PMID>12358660</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>June 19, 2012</study_first_submitted>
  <study_first_submitted_qc>October 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 9, 2013</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aga Khan University</investigator_affiliation>
    <investigator_full_name>Dileep Kumar</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Laryngeal Mask Airway</keyword>
  <keyword>Propofol</keyword>
  <keyword>Isoflurane</keyword>
  <keyword>Pediatric patients</keyword>
  <keyword>Emergence</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

